This 2026 statistics guide is designed for evidence review and measurement decisions in medical device, healthtech, and SaMD search programs. It is not a table of universally transferable performance norms.
For health-related publishing, treat YMYL and E-E-A-T as quality and trust review context, not as deterministic ranking formulas. Several source figures were previously published without supporting URLs or enough methodology to establish sample composition, geography, query set, attribution window, or causal effect.
The prior statement that 40-60% of the buyer journey is completed before sales contact is one example: preserve it as historical context that still needs source reconciliation rather than presenting it as verified market behavior. For decisions, compare each historical range with your own Search Console data, analytics, CRM records, content changes, and qualification rules.
For separate budget context, use the medtech SEO cost guide rather than treating cost and search performance as the same metric. This guide cannot guarantee compliance, and responsible legal, medical, or regulatory reviewers remain required for regulated claims, disclosures, and communications.